Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Observational Trial to Monitor the Incidence of Congenital Malformations in Infants of Women With an Ongoing Pregnancy After Controlled Ovarian Hyperstimulation Using Puregon® (recFSH)/Orgalutran® (Ganirelix) Followed by IVF/ICSI, or a Long Protocol With a GnRH Agonist as Historical Controls.

NCT00724789 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00724789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00724789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Observational Trial to Monitor the Incidence of Congenital Malformations in Infants of Women With an Ongoing Pregnancy After Controlled Ovarian Hyperstimulation Using Puregon® (recFSH)/Orgalutran® (Ganirelix) Followed by IVF/ICSI, or a Long Protocol With a GnRH Agonist as Historical Controls.
Lead sponsor
Organon and Co
Phase
Observational
Overall status
Completed
Start date
November 30, 2000
Completion date
November 30, 2005
Enrollment
2,066 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neonates, pregnancy